1 / 9

John Kanellopoulos, MD Associate Professor of Ophthalmology, NYU Medical School, NY, NY, USA

Novel Cornea OCT (cOCT) findings in early and long term follow up of collagen cross-linking (CXL) for keratoconus (KCN) ASCRS, Boston 2010. John Kanellopoulos, MD Associate Professor of Ophthalmology, NYU Medical School, NY, NY, USA Director, Laservision.gr Institute, Athens, Greece.

glen
Download Presentation

John Kanellopoulos, MD Associate Professor of Ophthalmology, NYU Medical School, NY, NY, USA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Novel Cornea OCT (cOCT) findings in early and long term follow up of collagen cross-linking (CXL) for keratoconus (KCN)ASCRS, Boston 2010 John Kanellopoulos, MD Associate Professor of Ophthalmology, NYU Medical School, NY, NY, USA Director, Laservision.gr Institute, Athens, Greece Financial interest: travel expense reimbursement from Wavelight(in the past) Kanellopoulos MD www.brilliantvision.con

  2. Introduction • The depth and degree of collagen cross-linking has been difficult to evaluate in clinical reality. By scanning some of these corneas with cOCT we encountered different findings than non-cxled corneas. We are therefore herein attemping to evaluate these novel, reproducible cornea OCT findings the first 6 months and at least 3 years following CXL (collagen cross-linking) for keratoconus Kanellopoulos MD www.brilliantvision.con

  3. Methods We evaluated a total of 125 KCN cases frm our clinical practice; 70 recent (group A) and 55 treated earlier (group B) were evaluated for the presence and stromal depth of intrastromal CXL lines (I-CXL-l), cornea thickness in microns (CT), UCVA, BSCVA, keratometry (K), topography, endothelium (ECC) and clarity. The Optovue OCT devise was used in this study Kanellopoulos MD www.brilliantvision.con

  4. Results 68 of Group A and 51 of group B cases demonstrated I-CXL-l. The mean values for group and group B were respectively: CT : 370, 380, I-CXL-l depth: 255, 262, UCVA: 20/60, 20/50, BSCVA: 20/40, 20/30, K: 49.5, 48.5, ECC: 2550, 2600. Mean follow-up: 7 , 38 months respectively Kanellopoulos MD www.brilliantvision.con

  5. A cornea OCT demonstrating hyper-reflective intra-corneal stromal “lines” at 2/3 depth (yellow arrows) corresponding with the clinical presence of CXL demarcation line in a patient, 3 years following the combined Topography guided-PRK/ and CXL procedure. Kanellopoulos MD www.brilliantvision.con

  6. Other examples Kanellopoulos MD www.brilliantvision.con

  7. Kanellopoulos MD www.brilliantvision.con

  8. Conclusions cOCT appears to demonstrate reproducible early and long-term CXL cornea findings. The hyper-reflective “lines’ may represent induced cornea density or subtle intrastromal cornea scarring This may constitute a possible novel non-invasive measurement, to evaluate and titrate the amount, extent and depth of intra-stromal effects of the CXL treatment in keratoconic and possibly ectasia eyes. Kanellopoulos MD www.brilliantvision.con

  9. Thank you www.brilliantvision.com Kanellopoulos MD www.brilliantvision.con

More Related